Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 2013
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Administration, Oral (MeSH)
- Anticoagulants (MeSH)
- Blood Coagulation (MeSH)
- Blood Coagulation Tests (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Drug Interactions (MeSH)
- Drug Monitoring (MeSH)
- Hemorrhage (MeSH)
- Humans (MeSH)
- Medication Adherence (MeSH)
- Patient Selection (MeSH)
- Predictive Value of Tests (MeSH)
- Risk Assessment (MeSH)
- Risk Factors (MeSH)
- Time Factors (MeSH)
- Treatment Outcome (MeSH)